Lilly in the migraine drug race

[anonymous]

http://alph.st/bf3c0558 Lilly joins the migraine drug race with Novartis and Amgen, as FDA accepts to review Lilly's Galcanezumab.

Already, Teva filed a lawsuit in October 2017, seeking to block Lilly's migraine drug to market in the U.S. The size of the migraine market is expected to more than triple ($25 billion) in 2025 from the current $3 billion.

 

[anonymous]

http://alph.st/bf3c0558 Lilly joins the migraine drug race with Novartis and Amgen, as FDA accepts to review Lilly's Galcanezumab.

Already, Teva filed a lawsuit in October 2017, seeking to block Lilly's migraine drug to market in the U.S. The size of the migraine market is expected to more than triple ($25 billion) in 2025 from the current $3 billion.

Well, you just need to deliver a better 'Customer Experience'. God, what a bunch of corporate MBA garbage. Just like Tesla where the SALESPEOPLE are called 'Customer Experience Delivery Specialists'.

Whatever happened to straightforward, honest language? How about Financial Advisor? Translation...salesperson.

By the way, these market forecasts come from sell-side financial analysts. In honest language, "investment banking hacks" These are the same dregs of society that said PCSK-9 would be a $10 billion a year market in CV disease. Sorry, but that isn't working out so well. PS - so long Jan Lundberg. Nice work while you were there.

 

[anonymous]

http://alph.st/bf3c0558 Lilly joins the migraine drug race with Novartis and Amgen, as FDA accepts to review Lilly's Galcanezumab.

Already, Teva filed a lawsuit in October 2017, seeking to block Lilly's migraine drug to market in the U.S. The size of the migraine market is expected to more than triple ($25 billion) in 2025 from the current $3 billion.

I really don’t get why Lilly continues to hire people for drugs that haven’t been approved yet! This is a stupid practice that has been done ALWAYS at the expense of the Diabetes Division! Didn’t Lilly learn it’s lesson by the stupid decisions it made in the early 2000’s that left Lilly at the bottom of the diabetes rat race that put Novo in the number one spot that really continues to this day! Don’t believe anything the higher -ups tell you! Novo is still number one!

 

[anonymous]

I love Hillary!

This afternoon, the State Department has just released the infamous batch of work-related emails from the account of top Hillary Clinton aide Huma Abedin that were discovered by the FBI on a laptop belonging to Abedin's estranged husband, and convicted pedophile, Anthony Weiner near the end of the 2016 presidential campaign.

As you may recall, the discovery of these emails on Weiner's computer is what prompted Comey to re-open the Hillary Clinton email investigation roughly 1 week prior to the election, a decision which the Hillary camp insists is the reason why they lost the White House.

Of course, while the Hillary campaign attempted to dismiss the emails as just another 'nothing burger', the Daily Mail reports that an initial review of the 2,800 documents dumped by the State Department reveal at least 5 emails classified at the 'confidential level,' the third most sensitive level the U.S. government uses.

The classified emails date from 2010-2012, and concern discussions with Middle East leaders, including those from the United Arab Emirates, Israel, the Palestinian Authority, and Hamas - which was declared a terrorist organization by the European Court of Justice in July. Large portions of the 2,800 page release were redacted prior to release by the State Department.

 

[anonymous]

Lilly is going to be in a tough battle vs Amgen and Alder. Not sure Lilly will have the Chops to win this race.....

 

[anonymous]

Any idea of the size of the sales team?

 

[anonymous]

The sales team has already been hired. All inexperienced. Lilly is only hiring millennials now. Straight out of college. No relationships with neurologists, unlike teva and Novartis who have been in there for years. Lilly is also notorious for launching poorly. Amgen and teva will clobber them.

 

[anonymous]

The sales team has already been hired. All inexperienced. Lilly is only hiring millennials now. Straight out of college. No relationships with neurologists, unlike teva and Novartis who have been in there for years. Lilly is also notorious for launching poorly. Amgen and teva will clobber them.

True, but you are missing a key component here.

Migraine docs are essentially whores, who are always looking for a buck. It’s almost like they have no idea what has changed in the industry. Probably from their Botox experience. Include them in your trials, put them on your speakers bureau, fund their little studies and they are ours.

 

[anonymous]

True, but you are missing a key component here.

Migraine docs are essentially whores, who are always looking for a buck. It’s almost like they have no idea what has changed in the industry. Probably from their Botox experience. Include them in your trials, put them on your speakers bureau, fund their little studies and they are ours.

OK, great idea. Now what do we do with the other 99% of docs writing migraine prescriptions?